Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 837,463 | 713,601 | 604,020 | 634,368 | 598,803 |
| Marketable Securities | 195,284 | 240,497 | 252,607 | 247,757 | 247,665 |
| Receivables | 149,582 | 141,257 | 122,917 | 73,750 | 82,102 |
| Inventories | 23,932 | 24,066 | 24,862 | 25,051 | 19,950 |
| TOTAL | $1,238,933 | $1,154,665 | $1,035,511 | $1,011,434 | $978,310 |
| Non-Current Assets | |||||
| PPE Net | 502,041 | 500,981 | 493,173 | 485,275 | 476,353 |
| Investments And Advances | 243,179 | 262,062 | 303,501 | 314,364 | 303,320 |
| Intangibles | 499,457 | 507,898 | 506,391 | 500,735 | 506,405 |
| Other Non-Current Assets | 186,209 | 181,033 | 176,133 | 221,746 | 208,718 |
| TOTAL | $1,430,886 | $1,451,974 | $1,479,198 | $1,522,120 | $1,494,796 |
| Total Assets | $2,669,819 | $2,606,639 | $2,514,709 | $2,533,554 | $2,473,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,970 | 18,200 | 14,408 | 14,373 | 12,728 |
| Accrued Expenses | 197,076 | 167,793 | 178,419 | 207,034 | 176,985 |
| TOTAL | $240,312 | $213,149 | $223,182 | $245,773 | $213,400 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,436 | 22,542 | 23,449 | 23,150 | 22,835 |
| Other Non-Current Liabilities | 203,670 | 201,948 | 198,667 | 107,369 | 101,061 |
| TOTAL | $241,588 | $239,512 | $235,603 | $143,939 | $137,327 |
| Total Liabilities | $481,900 | $452,661 | $458,785 | $389,712 | $350,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,647 | 104,112 | 103,525 | 102,289 | 102,038 |
| Common Shares | 103 | 102 | 102 | 101 | 101 |
| Retained earnings | 2,105,621 | 2,039,116 | 1,985,064 | 2,083,063 | 2,075,559 |
| Other shareholders' equity | -6,882 | 933 | -1,905 | -653 | -4,707 |
| TOTAL | $2,187,919 | $2,153,978 | $2,055,924 | $2,143,842 | $2,122,379 |
| Total Liabilities And Equity | $2,669,819 | $2,606,639 | $2,514,709 | $2,533,554 | $2,473,106 |